Aramark is scheduled to announce its financial results for the second quarter of fiscal year 2026 before the market opens on Tuesday, May 12. Market consensus suggests the company is poised for robust growth this quarter, driven by a favorable comparison to a lower base in the prior-year period and positive calendar effects.
Core Financial Expectations: Based on aggregated data from several institutions, analysts project Aramark's adjusted earnings per share (EPS) for Q2 to be $0.48, representing a year-over-year increase of approximately 41.2%. Revenue is expected to reach $4.76 billion, marking growth of about 10.7%. Furthermore, the company's full-year guidance remains unchanged: adjusted EPS for fiscal 2026 is forecasted to be in the range of $2.18 to $2.28, with organic revenue growth expected between 7% and 9%, and adjusted operating income growth projected from 12% to 17%.
Key Focus: Calendar Effect Reversal: A primary focus of this quarter's report is the reversal of the "calendar effect." As fiscal 2025 consisted of 53 weeks, the first-quarter performance was negatively impacted by approximately 3 percentage points. Management indicated at that time this factor would reverse in the second quarter, providing a benefit of a similar magnitude. Investors will be watching to confirm if this reversal materializes as anticipated and provides an additional boost to revenue and profit growth rates.
Segment Performance Expectations: By business segment, analysts anticipate the FSS North America division to report revenue of $3.39 billion, a 10.9% increase year-over-year. The FSS International division is expected to post revenue of $1.39 billion, up 14%. Adjusted operating income for these two major segments is projected to reach $214 million and $72 million, respectively, both reflecting double-digit growth. This performance is attributed to the continued benefits of new client contracts, improved supply chain efficiency, and technology applications.
Market Sentiment and Institutional Views: Several investment banks have recently raised their price targets for Aramark. For instance, UBS increased its target from $47 to $48 in early April, maintaining a "Buy" rating. The current market consensus rating is "Moderate Buy," with an average price target around $48.67. Investors will pay close attention to management's commentary during the earnings call regarding the maintenance of full-year guidance, cash flow improvements, and capital allocation plans.
The earnings conference call is scheduled for 8:30 AM Eastern Time on May 12.